Skip to main content
Premium Trial:

Request an Annual Quote

BioTek, Promega Integrate Platforms

NEW YORK (GenomeWeb News) – The microplate instrument and software maker BioTek Instruments is collaborating with Promega to offer a screening method for cell viability, cytotoxicity, and apoptosis.

The collaboration involves an integration of BioTek's Precision SX Automated Sample Processor and Promega's microwell cell-based assays that will provide a cell-based screening method to "obtain more biologically relevant data per well," the firms said.

BioTek Product Manager Jason Greene said in a statement that the company's sample processing platform cost, "ease of use, and small size lends itself to the small scale automation" of Promega's cell-based assays.

Terms of the collaboration were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more